Correction: Chisholm et al. Frontline and Relapsed Rhabdomyosarcoma (FaR-RMS) Clinical Trial: A Report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).


Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
09 Oct 2024
Historique:
received: 05 08 2024
accepted: 10 09 2024
medline: 16 10 2024
pubmed: 16 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

The authors wish to make corrections to the authorship and title of [...].

Identifiants

pubmed: 39410054
pii: cancers16193427
doi: 10.3390/cancers16193427
pii:
doi:

Types de publication

Published Erratum

Langues

eng

Commentaires et corrections

Type : ErratumFor

Auteurs

Julia Chisholm (J)

Children and Young People's Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton SM2 5PT, UK.

Henry Mandeville (H)

Children and Young People's Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton SM2 5PT, UK.

Madeleine Adams (M)

Children's Hospital for Wales, Cardiff CF14 4XW, UK.

Veronique Minard-Collin (V)

Department of Paediatric Oncology, Gustave Roussy, 75015 Paris, France.

Timothy Rogers (T)

Department of Paediatric Surgery, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS1 3NU, UK.

Anna Kelsey (A)

Department of Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK.

Janet Shipley (J)

The Institute of Cancer Research, London SW7 3RP, UK.

Rick R van Rijn (RR)

Department of Radiology and Nuclear Medicine, University of Amsterdam, Amsterdam UMC, 1081 HV Amsterdam, The Netherlands.

Isabelle de Vries (I)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Roelof van Ewijk (R)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Bart de Keizer (B)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Susanne A Gatz (SA)

Birmingham Women's and Children's NHS Foundation Trust, Birmingham B15 2TG, UK.
Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.

Michela Casanova (M)

Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy.

Lisa Lyngsie Hjalgrim (LL)

University Hospital Copenhagen, DK-2200 Copenhagen, Denmark.

Charlotte Firth (C)

Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.

Keith Wheatley (K)

Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.

Pamela Kearns (P)

Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.

Wenyu Liu (W)

Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.

Amanda Kirkham (A)

Cancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK.

Helen Rees (H)

Department of Paediatric Oncology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol BS1 3NU, UK.

Gianni Bisogno (G)

Department of Women and Children's Health, University of Padova, 35122 Padua, Italy.

Ajla Wasti (A)

The Institute of Cancer Research, London SW7 3RP, UK.

Sara Wakeling (S)

Alice's Arc Charity, London EC1V 1AW, UK.

Delphine Heenen (D)

KickCancer Foundation, 1000 Brussels, Belgium.

Deborah A Tweddle (DA)

Vivo Biobank, Translational & Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.

Johannes H M Merks (JHM)

Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.

Meriel Jenney (M)

Children's Hospital for Wales, Cardiff CF14 4XW, UK.

Classifications MeSH